Dr. Bhuvan Chugh

Professional Summary

Dr. Bhuvan Chugh is a distinguished Medical Oncologist and clinical leader with over 14 years of experience, known for his empathetic, clear, and evidence-based approach to cancer care. He specializes in Breast and Thoracic cancers, with a strong interest in using molecular oncology to personalize treatment and improve clinical decision-making. Currently serving as Lead Consultant, Medical Oncology at Apollo Hospitals (Delhi–NCR network), Dr. Chugh is recognized for practicing precision-led oncology, integrating genomic testing where it can meaningfully influence treatment strategy. His notable work includes CSF-based genomic sequencing-guided management in EGFR-mutant lung cancer with leptomeningeal disease, presented at ALKlinic 2025 and published in the Journal of Liquid Biopsy. He has also served as Past Convenor of the Max Healthcare–Foundation Medicine India Molecular Tumor Board, contributing to complex multidisciplinary decision-making across disease-site tumor boards. Dr. Chugh previously served as Principal Consultant, Medical Oncology at Max Super Specialty Hospital (Saket and Gurugram), gaining broad experience in managing complex cancers in a tertiary-care setting. His practice is firmly defined by patient-first care, evidence-based protocols, molecular oncology, and practical clinical judgment. He has presented his work at ASCO and ESMO through multiple abstracts and posters, and is also known for helping patients navigate difficult medical choices with clarity and confidence — an approach he has also shared as a TEDx speaker.

Specializations

- Medical Oncology

Procedures & Expertise

- Chemotherapy for Cancer
- Cancer Immunotherapy
- Targeted Therapy for Cancer
- Hormone Therapy for Breast Cancer
- Hormonal Therapy for Gynaecologic Cancers
- CAR-T Cell Therapy
- Hormone Therapy for Prostate Cancer

Education & Qualifications

- MBBS
- DNB (Medicine)
- DNB (Medical Oncology)

Hospital Affiliations

- Indraprastha Apollo Hospitals, Delhi
- Apollo Athenaa Women's Cancer Centre

Awards & Recognition

- ESMO Asia 2024 – Best Poster Award (co-author)
- Presented CSF genomic sequencing–guided management of leptomeningeal disease in EGFR-mutant NSCLC at ALKlinic 2025, Taipei, Taiwan
- Invited Speaker – SCCHN Preceptorship, Centre Antoine Lacassagne, Nice, France (November 2025)
- TEDx Speaker

Memberships

- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer (IASLC)
- Indian Society of Medical & Pediatric Oncology (ISMPO)
- Indian Medical Association (IMA) Oncology Forum

Research & Publications

- Circulating tumor cells in clinically stable patients demonstrates the conundrum of recurrence with cellular residual disease — ASCO Annual Meeting 2024
- Differences in the Clinicopathological Feature, Prognostic Features and Treatment Outcomes between Molecular Subtypes Among Indian Cohort with Diffuse Large B-Cell Lymphoma — Blood 134 (Supplement_1):5350-5350; November 2019